Revenue ($USD) : $6,940,208,583
Revenue (foreign currencies) : JP¥975,100,000,000
R&D spend : Not Available
Employees : Not Available
Fiscal year end : 3/31/2024
CEO : Teiichi Goto

www.fujifilm.com/us/en/healthcare

Healthcare is the largest operating segment within Fujifilm, responsible for nearly a third of the company’s revenue in fiscal 2024, with sales for the segment up 5% for the year. Fujifilm’s healthcare products include diagnostic equipment such as X-ray systems, endoscopes and ultrasound systems, and medical IT systems. Fujifilm Healthcare Americas is headquartered in Lexington, Massachusetts. Top Fujifilm healthcare news in 2024 included the company picking Brainlab to exclusively distribute its Arietta Precision ultrasound for neurosurgery applications in the U.S. The companies said Arietta Precision combined with Brainlab’s surgical navigation system “becomes a powerful intraoperative neurosurgery solution.” Fujifilm also won FDA clearance of its CAD Eye AI-powered detection system for endoscopic imaging, a system that could compete against Medtronic and Cosmo Intelligent Medical Devices’ GI Genius for colonoscopies. –CN and SW